1 |
Zhang M, Xin W, Yu Y, et al. Programmed death-ligand 1 triggers PASMCs pyroptosis and pulmonary vascular fibrosis in pulmonary hypertension[J]. J Mol Cell Cardiol, 2020, 138:23-33.
|
2 |
Gorelova A, Berman M, Al Ghouleh I. Endothelial-to-mesenchymal transition in pulmonary arterial hypertension[J]. Antioxid Redox Signal, 2021, 34(12):891-914.
|
3 |
Kazmirczak F, Vogel NT, Prisco SZ. Ferroptosis mediated inflammation promotes pulmonary hypertension[J]. Circ Res, 2024, 135(11):1067-1083.
|
4 |
Wu D, Jansen-van Vuuren RD, Dasgupta A. Novel Drp1 GTPase inhibitor, drpitor1a: efficacy in pulmonary hypertension[J].Hypertension, 2024, 81(10):2189-2201.
|
5 |
Zhang JJ, Mao M, Shao MM, et al. Therapeutic potential of natural flavonoids in pulmonary arterial hypertension: A review[J].Phytomedicine. 2024, 128:155535. doi: 10.1016/j.phymed.2024.155535.
|
6 |
Chu LH, Indramohan M, Ratsimandresy RA, et al. The oxidized phospholipid oxPAPC protects from septic shock by targeting the noncanonical inflammasome in macrophages[J]. Nat Commun, 2018,9(1):996. doi: 10.1038/s41467-018-03409-3.
|
7 |
Jiang Y, Liu H, Yu H, et al. Circular RNA calm4 regulates hypoxia- induced pulmonary arterial smooth muscle cells pyroptosis via the Circ-Calm4/miR-124-3p/PDCD6 Axis[J]. Arterioscler Thromb Vasc Biol. 2021, 41(5):1675-1693.
|
8 |
Zhu J, Zhou W, Yao Y, et al. Targeted positron emission tomography- tracked biomimetic codelivery synergistically amplifies ferroptosis and pyroptosis for inducing lung cancer regression and Anti-PD-L1 immunotherapy efficacy[J]. ACS Nano, 2024, 18(45):31401-31420.
|
9 |
He X, Wu Z, Jiang J, et al. Urolithin a protects against hypoxia-induced pulmonary hypertension by inhibiting pulmonary arterial smooth muscle cell pyroptosis via AMPK/NF-κB/NLRP3 Signaling[J]. Int J Mol Sci, 2024, 25(15):8246. doi: 10.3390/ijms25158246.
|
10 |
Mannini L, Cucco F, Quarantotti V, et al. SMC1B is present in mammalian somatic cells and interacts with mitotic cohesin proteins[J].Sci Rep, 2015, 5:18472. doi: 10.1038/srep18472.
|
11 |
Ma RM, Yang F, Huang DP, et al. The prognostic value of the expression of SMC4 mRNA in breast cancer[J]. Dis Markers, 2019,2019:2183057. doi: 10.1155/2019/2183057.
|
12 |
Jiang L, Zhou J, Zhong D, et al. Overexpression of SMC4 activates TGFβ/Smad signaling and promotes aggressive phenotype in glioma cells[J]. Oncogenesis, 2017, 6(3):e301. doi: 10.1038/oncsis.2017.8.
|
13 |
Zhang C, Kuang M, Li M, et al. SMC4, which is essentially involved in lung development, is associated with lung adenocarcinoma progression[J]. Sci Rep, 2016, 6:34508. doi: 10.1038/srep34508.
|
14 |
Chen Y, Huang F, Deng L, et al. HIF-1-miR-219-SMC4 regulatory pathway promoting proliferation and migration of HCC under hypoxic condition[J]. Biomed Res Int, 2019, 2019:8983704. doi:10.1155/2019/8983704.
|
15 |
Wang Q, Wang C, Li N, et al. Condensin Smc4 promotes inflammatory innate immune response by epigenetically enhancing NEMO transcription[J]. J Autoimmun, 2018, 92:67-76.
|
16 |
Guo Q, Jin Y, Chen X, et al. NF-κB in biology and targeted therapy:new insights and translational implications[J]. Signal Transduct Target Ther, 2024, 9(1):53. doi: 10.1038/s41392-024-01757-9.
|
17 |
Hsu H, Xiong J, Goeddel DV. The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation[J]. Cell, 1995,81(4):495-504.
|
18 |
Yang Z, Pan X, Wu X, et al. TREM-1 induces pyroptosis in cardiomyocytes by activating NLRP3 inflammasome through the SMC4/NEMO pathway[J]. FEBS J, 2023, 290(6):1549-1562.
|
19 |
Jiang Y, Song S, Liu J, et al. Epigenetic regulation of programmed cell death in hypoxia-induced pulmonary arterial hypertension[J]. Front Immunol, 2023, 14:1206452. doi: 10.3389/fimmu.2023.1206452.
|
20 |
Xi J, Ma Y, Liu D, et al. Astragaloside IV restrains pyroptosis and fibrotic development of pulmonary artery smooth muscle cells to ameliorate pulmonary artery hypertension through the PHD2/HIF1α signaling pathway[J]. BMC Pulm Med, 2023, 23(1):386. doi: 10.1186/s12890-023-02660-9.
|
21 |
李尚,吕婷婷,张子睿,等. 基因治疗在肺动脉高压中的研究进展 [J].江苏大学学报(医学版), 2022, 32 (03): 200-206.
|
22 |
Broz P, Pelegrín P. The gasdermins, a protein family executing cell death and inflammation[J]. Nat Rev Immunol, 2020, 20(3):143-157.
|
23 |
Gordon R, Albornoz EA. Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice[J]. Sci Transl Med, 2018, 10(465):eaah4066. doi: 10.1126/scitranslmed.aah4066.
|
24 |
Yang F, Qin Y, Wang Y, et al. LncRNA KCNQ1OT1 mediates pyroptosis in diabetic cardiomyopathy[J]. Cell Physiol Biochem, 2018,50(4):1230-1244.
|
25 |
Zhou QY, Liu W, Gong SX, et al. Pulmonary artery smooth muscle cell pyroptosis promotes the proliferation of PASMCs by paracrine IL-1β and IL-18 in monocrotaline-induced pulmonary arterial hypertensive rats[J]. Exp Ther Med, 2024, 28(4):394. doi: 10.3892/etm.2024.12683.
|
26 |
Uhlmann F. SMC complexes: from DNA to chromosomes[J]. Nat Rev Mol Cell Biol, 2016, 17(7):399-412.
|
27 |
Wood AJ, Severson AF, Meyer BJ. Condensin and cohesin complexity:the expanding repertoire of functions[J]. Nat Rev Genet, 2010,11(6):391-404.
|
28 |
Swanson KV, Deng M. The NLRP3 inflammasome:molecular activation and regulation to therapeutics[J]. Nat Rev Immunol, 2019,19(8):477-489.
|
29 |
Zheng X, Chen W, Gong F, et al. The role and mechanism of pyroptosis and potential therapeutic targets in sepsis: a review[J]. Front Immunol,2021, 12:711939. doi: 10.3389/fimmu.2021.711939.
|
30 |
Ma C, Liu S, Zhang S, et al. Evidence and perspective for the role of the NLRP3 inflammasome signaling pathway in ischemic stroke and its therapeutic potential (Review)[J]. Int J Mol Med, 2018, 42(6):2979-2990.
|
31 |
Rabinovitch M, Guignabert C, Humbert M, et al. Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension[J].Circ Res, 2014, 115(1):165-175.
|
32 |
Dai L, Chen Y, Wu J, et al. A novel complement C3 inhibitor CP40- KK protects against experimental pulmonary arterial hypertension via an inflammasome NLRP3 associated pathway[J]. J Transl Med, 2024,22(1):164. doi: 10.1186/s12967-023-04741-z.
|
33 |
Simpson CE, Chen JY, Damico RL, et al. Cellular sources of interleukin-6 and associations with clinical phenotypes and outcomes in pulmonary arterial hypertension[J]. Eur Respir J, 2020, 55(4):1901761.doi: 10.1183/13993003.01761-2019.
|
34 |
Li Y, Zhang YT, Han B, et al. Single-cell sequencing analysis confirms the association of ANRIL with the increased smooth muscle cell proliferation and migration gene signatures in pulmonary artery hypertension in silico[J]. Adv Med Sci, 2024, 69(2):217-223.
|
35 |
Luo J, Li H, Liu Z, et al. Integrative analyses of gene expression profile reveal potential crucial roles of mitotic cell cycle and microtubule cytoskeleton in pulmonary artery hypertension[J]. BMC Med Genomics, 2020, 13(1):86. doi: 10.1186/s12920-020-00740-x.
|
36 |
Hergalant S, Saurel C, Divoux M. Correlation between DNA methylation and cell proliferation identifies new candidate predictive markers in meningioma[J]. Cancers (Basel), 2022, 14(24):6227. doi:10.3390/cancers14246227.
|